Cargando…
Furazolidone-based Therapies for Helicobacter pylori Infection: A Pooled-data Analysis
BACKGROUND/AIM: Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do e...
Autores principales: | Zullo, Angelo, Ierardi, Enzo, Hassan, Cesare, Francesco, Vincenzo De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271687/ https://www.ncbi.nlm.nih.gov/pubmed/22249086 http://dx.doi.org/10.4103/1319-3767.91729 |
Ejemplares similares
-
Furazolidone and Helicobacter pylori Treatment
por: Talebi Bezmin Abadi, Amin
Publicado: (2015) -
Resistance of Helicobacter pylori to furazolidone and levofloxacin: A viewpoint
por: Zamani, Mohammad, et al.
Publicado: (2017) -
Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication
por: Zhang, Ya-Wen, et al.
Publicado: (2018) -
Furazolidone-induced pulmonary toxicity in Helicobacter pylori infection: Two case reports
por: Ye, Yao, et al.
Publicado: (2023) -
Helicobacter pylori and portal hypertensive gastropathy: any new information?
por: Zullo, Angelo, et al.
Publicado: (2014)